Sales 2024 * | 12.22M 16.74M | Sales 2025 * | 5.87M 8.04M | Capitalization | 171M 234M |
---|---|---|---|---|---|
Net income 2024 * | -29M -39.71M | Net income 2025 * | -32M -43.82M | EV / Sales 2024 * | 14 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 29.1 x |
P/E ratio 2024 * |
-6.95
x | P/E ratio 2025 * |
-5.25
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 99.56% |
Latest transcript on BioTime, Inc.
Managers | Title | Age | Since |
---|---|---|---|
Brian Culley
CEO | Chief Executive Officer | 53 | 18-09-16 |
Jill Howe
DFI | Director of Finance/CFO | 48 | 22-11-13 |
Chief Operating Officer | - | 09-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Neal Bradsher
BRD | Director/Board Member | 58 | 09-06-30 |
Brian Culley
CEO | Chief Executive Officer | 53 | 18-09-16 |
Deborah Andrews
BRD | Director/Board Member | 66 | 14-04-10 |
1st Jan change | Capi. | |
---|---|---|
+34.14% | 51.12B | |
-6.54% | 39.4B | |
+34.92% | 38.48B | |
+12.62% | 26.36B | |
-12.11% | 26.22B | |
-13.43% | 20.96B | |
+43.73% | 14.02B | |
+31.81% | 12.49B | |
-4.54% | 11.61B |